Expanding Approved Stem Cell Lines in Ethically Responsible Ways
Headline: Expands Federal Support for Ethical Stem Cell Research for Patients
What it does: Federal health agencies must fund and plan research to derive and test pluripotent stem cells without creating or destroying embryos.
- Adds eligible non-embryo-derived stem cell lines to the national registry.
- Directs federal funding and research priorities toward non-embryo-derived stem cells.
- Requires an annual report to the President on research activities and developments.
Summary
This order directs the Department of Health and Human Services, including the national medical research institutes, to conduct and support research into pluripotent stem cells that can become most body cell types but are derived without creating or destroying human embryos. Within 90 days the department must issue a plan using funding requests and program announcements and add eligible cell lines to the national registry.
Scientists, patients seeking new treatments, and taxpayers funding research will be affected. The order aims to advance medical knowledge while upholding ethical limits on embryo use.
Ask about this order
Ask questions about this executive order and its implications.
What agencies are affected by this order?
How does this order change existing policy?
What are the practical implications of this order?